About

Hypertension is the most common modifiable risk factor for cardiovascular disease and death, and lowering blood pressure with antihypertensive drugs reduces target organ damage and prevents cardiovascular disease outcomes.

Most hypertensive patients will need a combination of antihypertensive agents to achieve the therapeutic goals. Recent guidelines recommend initiating treatment with two drugs in those patients with a systolic blood pressure >20 mmHg and/or a diastolic blood pressure >10 mmHg above the goals, and in those patients with high cardiovascular risk. In addition, approximately 25% of patients will require three antihypertensive agents to achieve the therapeutic targets.

Articles

NT-BNP in Stable Coronary Artery Disease

Citation:

US Cardiology 2006;3(2):43-6

Past, Present and Future of Stress Echocardiography - How Far Have We Come and How Far Can We Go?

Citation:

US Cardiology 2008;5(1):28–30

Developments in the Treatment of Hypertension

Citation:

US Cardiology 2007;4(2):68–70

Cardiovascular Risk in Type 2 Diabetes - Reflecting on the ADVANCE Study

Citation:

US Cardiology 2009;6(2):46–50